15-12G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-40316

 

 

VECTIVBIO HOLDING AG

(Exact name of registrant as specified in its charter)

 

 

Aeschenvorstadt 36

4051 Basel, Switzerland

+41 615513030

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Ordinary Shares, nominal value of CHF 0.05 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

 

Rule 12g-4(a)(2)

 

Rule 12h-3(b)(1)(i)

 

Rule 12h-3(b)(1)(ii)

 

Rule 15d-6

 

Rule 15d-22(b)

 

Approximate number of holders of record as of the certification or notice date: Four (4)

Pursuant to the requirements of the Securities Exchange Act of 1934, VectivBio Holding AG has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

    VECTIVBIO HOLDING AG
Date: July 24, 2023     By:  

/s/ Sravan K. Emany

    Name:   Sravan K. Emany
    Title:   Authorized Representative